제이에스링크

127120KOSDAQSector: Pharma & Biotech

₩32,600▲ 1.24%Market cap ₩1.13TAs of Jul 21, 2026 close · updated once daily

Grade D32.8 ptsTop 82% of 2,523 stocks

Financial strength

30.7

Growth momentum

40.6

Price attractiveness

29.5

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

Financial strength

30.7

How much debt does it carry relative to equity?

Debt-to-equity ratio

79.4%

✗ Below median · Top 66.9% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

114.4%

✗ Below median · Top 70.5% in sector

Sector median 191.3%

How much of revenue becomes profit?

Operating margin

-64.6%

✗ Below median · Top 70.2% in sector

Sector median -2.3%

How much did it earn on its own capital?

ROE (return on equity)

-24.0%

✗ Below median · Top 69.7% in sector

Sector median -4.5%

Source filing: annual report (consolidated) — view original ↗

Growth momentum

40.6

How much did revenue grow in a year?

Revenue growth (YoY)

21.4%

✓ Above median · Top 22.1% in sector

Sector median 6.4%

Has it grown steadily over three years?

Revenue 3-year CAGR

4.4%

✗ Below median · Top 51.4% in sector

Sector median 4.9%

Did core profits grow in a year?

Operating income change (YoY)

-37.0%

✗ Below median · Top 78.3% in sector

Sector median 3.6%

Are core profits higher than three years ago?

Operating income change (3Y)

-142.6%

✗ Below median · Top 85.8% in sector

Sector median 3.5%

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

29.5

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✓ Above median · Top 49.8% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

16.50x

✗ Below median · Top 91.3% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15